Skip to content
Search

Latest Stories

Submit Guest Post

Yusuf Pathan banned for failed drugs test

India on Tuesday suspended former international all-rounder Yusuf Pathan for five months for taking a banned stimulant.

The ban on the 35-year-old, who last represented India in 2012, was backdated so that it ends on January 14.


The Board of Control for Cricket in India said the explosive batsman was routinely tested during domestic Twenty20 competition last year and a sample showed traces of Terbutaline.

But the board said it was satisfied with Pathan's explanation that the substance entered his body through medication while taking a cough syrup and "not as a performance-enhancing drug".

Pathan, who also bowls off-spin, played 57 one-day internationals and 22 T20 games for India and has been an Indian Premier League regular. In 2014 he hit the IPL's fastest 50 off just 15 balls.

He is only the second Indian cricketer to fail a dope test. In 2013 Delhi left-arm paceman Pradeep Sangwan was banned for 18 months.

The BCCI strongly opposes tests by India's National Anti-Doping Agency. It insists that as a member of the International Cricket Council -- a signatory to the World Anti-Doping Agency -- it already has strict anti-doping rules.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

NatWest

The filings show NatWest provided funding to Castor Financing, a business that financed Amplifi, between 2023 and 2025.

AFP via Getty Images

NatWest financing tied to Amplifi before consumer lender's collapse: Report

NATWEST helped fund London-based consumer credit firm Amplifi Capital with up to £250 million before the company entered insolvency last month, according to company filings reviewed by Reuters.

The filings show NatWest provided funding to Castor Financing, a business that financed Amplifi, between 2023 and 2025. The links, which have not previously been reported, highlight how banks have provided funding to non-bank financial institutions (NBFIs) as regulators continue to examine risks linked to the sector.

Keep ReadingShow less